There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
The former England captain took to Instagram to show off his pancake flipping skills on Shrove Tuesday - and poked fun at his son's efforts.
A drier set up in the next day or so with colder air seeping in and temperatures sliding away.
Dropping 1%, the FTSE 100 index is now at levels not seen since 2012.